Summary Zinc phthalocyanine (ZnPc) is a second-generation photosensitiser for the photodynamic therapy (PDT) of cancer. Unsubstituted ZnPc is, however, highly insoluble in most common solvents, and for clinical applications the material needs to be incorporated in liposomes. We report a simple, alternative procedure to formulate ZnPc through non-covalent binding to bovine serum albumin (BSA). Intravenous administration of ZnPc-BSA preparations, at a molar ratio of 11: 1 and at a ZnPc dose equivalent to 0.5 mol kg-, to tumourbearing mice followed 24 h later by PDT was shown to provide tumour control in two different models, the EMT-6 tumour in Balb/c mice and the human colon T380 carcinoma in nude mice. Analysis of serum fractions from treated animals showed that ZnPc readily redistributes over the serum high-density lipoprotein (HDL) fraction. We also demonstrated the absence of hepatic toxicity of the ZnPc-BSA preparation by monitoring the hepatic cytochrome P450 activiy in treated animals and the viability of human cultured hepatocytes.
Fluorescence properties and preferential retention of dyes in malignant tissues allow the clinical diagnosis of various human neoplasms (Dougherty et al., 1978) . If the photoexcited dyes are capable of in situ energy or electron transfer, they can also be used as sensitisers for the photodynamic therapy (PDT) of tumours. The most widely studied dye for PDT, Photofrin (Pll), consists of a mixture of haematoporphyrin derivatives, and this preparation has been approved for clinical use (Levy, 1995) . However, the relatively low absorbance above 600 nm (at which tissues provide optimal transparency) and some pharmacodynamic drawbacks have led to the development of new dyes for PDT (Morgan et al., 1988; van Lier, 1988) . Among them, the phthalocyanines (Pc) have advantageous photophysical properties and numerous studies have been conducted to demonstrate the potential of these molecules for PDT (van Lier, 1990; Rosenthal, 1991) .
Low solubility of the non-substituted metallo Pcs in biological fluids prompted chemical modifications to decrease their hydrophobicity Chan et al., 1990) . Albeit such changes may result in a decrease in their in vivo photoactivity, mono-and di-sulphonated derivatives are capable of cell membrane penetration resulting in increased potency to inflict direct cell kill during PDT (Brasseur et al., 1988; Paquette and van Lier, 1992; Margaron et al., 1996) . Among the non-substituted Pcs, the zinc complex (ZnPc) has been studied in great detail (Ginevra et al., 1990; Reddi et al., 1990) . Owing to its extreme insolubility in most common solvents, ZnPc needs to be incorporated in liposomes, and a proprietary formulation has been proposed for clinical use (Schieweck et al., 1994) .
In this study, we evaluate the PDT potential of the readily available, unsubstituted ZnPc solubilised with bovine serum albumin (BSA) and compare its PDT potency with that of two sulphonated ZnPcS derivatives. Photodynamic properties of the latter dyes have previously been reported in mice bearing the sarcoma type EMT-6 mouse mammary tumour (Paquette and van Lier, 1992) , and we used the same model in the present study. In addition, we evaluated tumour control by ZnPc -BSA -PDT in the human colonic carcinoma T380 implanted in nude mice. The dark toxicity and possible effects of this preparation on mouse liverdetoxifying enzymes, such as cytochromes P450 and glutathione transferase, is evaluaied. Behaviour of human cultured hepatocytes exposed to the ZnPc-BSA preparation is also reported.
Materials and methods
Animals and tumour models Mice were maintained and handled in accordance with the recommendations of a local animal care committee. The animals were allowed free access to water and food throughout the course of the experiment. The EMT6 mouse mammary tumour cell line was obtained from Dr C-W Lin (Massachusetts General Hospital, Boston) and maintained according to an established protocol (Rockwell et al., 1972) . Tumours were implanted in Balb/c mice on each hind thigh by intradermal injection of 2 x 105 EMT6 cells suspended in 50 !l of Waymouth growth medium. The human colon carcinoma T380 (Martin and Halpern, 1984) was serially transplanted subcutaneously into the right flank of 7-to 9-week-old female Swiss nu/nu mice (Iffra Credo, l'Arbresle, France). After 2 weeks, the mice were randomised to different treatment and control groups. Both models were used for PDT when tumours reached at least 8 -10 mm in diameter. The tumour volume on nude mice was evaluated by measuring the tumour diameters (three dimensions) and applying the formula volume = rI x r2 x r3 x 47r/3 (r= radius).
Zinc phthalocyanine-albumin preparation Zinc phthalocyanine (Aldrich 34,116-9) was prepared as a saturated (1.7 mM) dimethylformamide (DMF) solution. This solution was added dropwise to a 1 mg ml-' bovine serum albumin (BSA) preparation in phosphate buffer (50 mM, pH 7.4) under gentle stirring. The final DMF concentration did not exceed 5%. Solid ammonium sulphate (0.625 g ml-', 85% saturation) was added to the mixture, which was then stirred at 4°C for 10 min and centrifuged at 10 000 g for 10 min. The clear supernatant was discarded and the coloured pellet was redissolved in phosphate buffer. This procedure was repeated until the ZnPc-BSA ratio remained stable. The final preparation was dialysed overnight against PBS to remove the excess of ammonium sulphate and used immediately or lyophylised. The lyophylised ZnPc-BSA preparation can be reconstituted in PBS and this solution was shown to be stable for several weeks at 4°C. ZnPc -BSA ratios were measured after a 100-fold dilution in DMF (ZnPc: .max = 678 nm, £ = 2.45x 105 M-' cm-1).
Phototherapy
Either Balb/c or nude tumour-bearing mice were given an intravenous injection of the dye preparation via the lateral tail vein (maximal volume 0.2 ml). Phototherapy was applied 24 h after dye administration. EMT-6 or T380 tumourbearing mice were anaesthetised with an intraperitoneal injection of tribromoethanol (230 mg kg-' in PBS, 10% ethanol). The tumours were centred under the red spot (diameter 1 -1.5 mm) of a light source consisting of a focalised Xenon Cermax LX-300 F (ILC Technology, Sunnyvale, CA, USA) fitted with a 10 cm long water cell to remove infrared radiation and a 676 nm interference filter (bandpass + 10 nm) (Optometrics, Leeds, UK). Illumination times were adjusted to deliver the desired light dose, as measured with a Photon Power Meter (Spectra-Physics Model 404). No hyperthermia was observed under these conditions. Response of the EMT-6 tumour was assessed by observation of the tumour necrosis followed by the absence of palpable tumour within 3 weeks after the treatment. In the case of the T380 tumours, the measurement of the tumour volume over a 2 month period was used to assess tumour response.
Fractionation of serum proteins Balb/c mice blood was collected 24 h after injection of the ZnPc -BSA (11: 1) preparation (2 ,mol of ZnPc per kg) and the serum was separated after a short centrifugation. The various protein components were then separated on a potassium bromide density gradient in a Beckman VTi 65-2 rotor operating at 60 000 g for 2 h (Chung et al., 1986) . The potassium bromide concentration was adjusted in order to obtain a final gradient density between 1.06 and 1.22. Fractions were then recovered from the top of the tube. The density of each fraction was monitored using a thermostated PAAR DMA 40 Digital Density Meter (Anton Parr, Graz, Austria) and ZnPc fluorescence was measured on an Aminco-Bowman spectrofluorimeter (ex =646 nm, ,em =680 nm, 5 nm bandpass) after calibration of the apparatus with successive dilutions of ZnPc in mouse serum. The nature of the proteins in each fraction was verified by polyacrylamide gel electrophoresis. The amont of total protein was estimated using the BCA method (Pierce, Rockford, MA) and bromocresol green was used to quantify albumin specifically in each fraction (Doumas et al., 1971) .
Liver detoxification
Balb/c mice were injected intraperitoneally with a ZnPc BSA (1 1: 1) preparation (ZnPc dose of 2 pmol kg-') over a 4 day period. On day 5, the animals were sacrificed, livers removed and the microsomal and cytosolic fraction prepared. Progesterone is a good substrate for hepatic cytochrome P-450, and the pattern of metabolites is indicative of the concentration and nature of the various hydroxylases. Microsomal metabolic profiles of progesterone were prepared as previously described (Larroque et al., 1989) .
Enzymatic assays and human hepatocyte handling Microsomes and cytosol from treated or untreated mice were prepared by successive centrifugation as previously described (Lu and Levin, 1972) . The microsomal cytochrome P-450 activity was tested using progesterone as substrate, and the metabolite composition was analysed after thin-layer chromatography and liquid scintillation counting (Larroque et al., 1989) . Total glutathione-S-transferase activity was assayed on the cytosolic fraction with 1-chloro-2,4-dinitrobenzene as substrate (Habig et al., 1974) . Human hepatocytes were prepared from hepatic lobectomies (as approved by the French National Ethics Committee), and cultured in a serumfree medium as previously described (Diaz et al., 1990) . The overall metabolic integrity of hepatocytes in culture was assessed by measuring the rate of de novo protein synthesis in 24 h (Pichard et al., 1992) , after the cells have been incubated in the dark for 6 days with various concentrations of the ZnPc-BSA preparation. All of the chemicals used in this study were of the highest purity commercially available.
Results Figure 1 shows the electronic spectrum of a ZnPc-BSA preparation. Superimposed is the transmission of the red light source. The relatively short bandpass from the 676 nm interference filter limits unwanted interactions with endogenous porphyrins. For a typical ZnPc-BSA preparation the dye content was 11 mol of ZnPc per mol of BSA. A lower ratio diminished the PDT potency, whereas a higher loading ratio did not improve tumour response.
Photodynamic therapy
The PDT efficacy of ZnPc-BSA was first compared with the known activities of the mono-and tetra-sulphonated ZnPcS1 and ZnPcS4 in Balb/c mice bearing EMT-6 mammary tumours. Tumour responses, after irradiation with red light (. = 676 nm, 400 J cm-2, 100 mW cm-2) 24 h after injection of the various photosensitiser preparations, are summarised in Table I . These data show that tumour control can be achieved under these conditions with ZnPc-BSA at a ZnPc dose level of 0.5 pmol kg-'. These results demonstrate that absorption of commercially available ZnPc to serum albumin provide a dye preparation with similar PDT efficacy to the synthetic, water-soluble ZnPcS, preparation. These data growth to an average tumour size of 500 mg on day 24 after inoculaltion ( Figure 2 ). In the tre'ated group, the 500 mg tuIllour sizc was observed only on day 49 after the tumour implant. high-density lipoproteinis (Gotto ci tl.., 1986). This ZnPc distributioni profile contrasts with the pattern observed by Ginevra ct al. (1990) Effect of ZnPc-BSA on human cultured hepatocytes As stated, phthalocyanines are easily trapped by the liver. The capacity of human hepatocytes to synthesise proteins after 6 days of incubation with various concentrations of ZnPc-BSA is seen in Figure 4 . The lowest concentration used (e.g. 6 iM of BSA-bound ZnPc) corresponds to the maximum ZnPc concentration in the serum of mice that received ZnPc-BSA equivalent to a ZnPc dose of 1 ,umol kg-'. As can be seen from Figure 4 , toxicity only becomes evident at ZnPc concentrations exceeding 30 gM.
This observation is in line with our other findings and confirms the relatively low toxicity of the ZnPc-BSA preparation.
Discussion
The delivery of hydrophobic dyes to tumour cells has been proposed to proceed via a transport by lipoproteins (Ginevra et al., 1990 ). The present study demonstrates that the BSAdelivered ZnPc readily redistributes from the carrier protein to the serum lipoproteins, particularly the HDL fraction. Thus, the in vivo PDT effect following ZnPc-BSA administration is likely to involve the same mechanism as that observed with similar dyes delivered via liposomal preparations . Compared with the latter, ZnPc loading on albumin is a relatively simple procedure (Schieweck et al., 1994) . To avoid antigenecity problems, it is evident that the same procedure can be used with human albumin preparations.
The PDT efficacy of the ZnPc -BSA is similar to that of the monosulphonated ZnPcS,. However, the latter preparation requires extensive chromatographic purification and consists of a mixture of positional isomers . Accordingly, the ZnPc-albumin formulation promises to be more suitable for scaling up to the quantities required in a clinical setting.
The liver is the principal site for the oxidation and detoxification of foreign materials, and the lipophilic phthalocyanines are known to be largely retained by the liver. Previous in vitro studies on isolated liver microsomes demonstrated the deleterious effect of phthalocyanine on these structures (Agarwal et al., 1992) . To mimic more closely the photodynamic protocol, we studied the in vivo effect of ZnPc-BSA on some essential liver functions. Finally, we showed for the first time the lack of hepatic dark toxicity of ZnPc, even at relative high dye concentrations. However, the apparent accumulation of the dye in the liver remains a problem, necessitating the use of lower light doses in our nude mice model. Although the BSA vehicle allowed the biodistribution of the dye throughout the whole animal, increased tumour selectivity would obviously be desirable. Covalent coupling of other dyes (fluorescein, indocyanin) to a monoclonal antibody directed against tumour cells in nude mice bearing colon or squamous cell carcinomas has been demonstrated (Folli et al., 1992 (Folli et al., , 1994 Pelegrin et al., 1991) , and a similar approach for ZnPc targeting may further enhance tumour specificity.
